DrugPatentWatch Database Preview
Drugs in Development Information for Vintafolide
» See Plans and Pricing
What is the drug development status for Vintafolide?
Vintafolide is an investigational drug.
There have been 9 clinical trials for Vintafolide.
The most recent clinical trial was a Phase 2 trial, which was initiated on August 1st 2007.
The most common disease conditions in clinical trials are Lung Neoplasms, Ovarian Neoplasms, and Adenocarcinoma. The leading clinical trial sponsors are Endocyte and [disabled in preview].
Summary for Vintafolide
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 0 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2007-08-01) |
| Vendors | 0 |
Recent Clinical Trials for Vintafolide
| Title | Sponsor | Phase |
|---|---|---|
| Safety and Efficacy Study of Vintafolide and Vintafolide Plus Paclitaxel Compared to Paclitaxel Alone in Participants With Triple Negative Breast Cancer (TNBC) (MK-8109-004) | Endocyte | Phase 2 |
| A Study of Vintafolide (MK-8109) in Participants With Advanced Solid Tumor (MK-8109-011) | Endocyte | Phase 1 |
| A Study of MK-8109 (Vintafolide) Given Alone or With Chemotherapy in Participants With Advanced Cancers (MK-8109-001) | Endocyte | Phase 1 |
Clinical Trial Summary for Vintafolide
Top disease conditions for Vintafolide
Top clinical trial sponsors for Vintafolide
US Patents for Vintafolide
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
